CITIGROUP INC

Position in PYXS — Pyxis Oncology, Inc.

CIK 831001 NEW YORK, NY

Position in PYXS

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$2,540

-$797 QoQ

Shares Held

1,740

-40.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#64

of 78 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

CITIGROUP INC holds $1,428,056,604 across 399 Biotechnology names. PYXS ranks #330 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	682,807	$304,900,636
2	REGN	Regeneron Pharmaceuticals, Inc.	184,691	$142,699,654
3	ALNY	Alnylam Pharmaceuticals, Inc.	263,375	$87,142,884
4	MRNA	Moderna, Inc.	1,480,034	$75,185,727
5	FOLD	AMICUS THERAPEUTICS, INC.	4,226,882	$61,120,713
6	BBIO	BridgeBio Pharma, Inc.	746,483	$55,433,827
7	INCY	Incyte Corp	489,649	$46,085,763
8	ROIV	Roivant Sciences Ltd.	1,536,110	$42,550,246

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,540	1,740	-40.0%	Shares	Defined	2026-05-11
2025-12-31	$3,337	2,902	+126.5%	Shares	Defined	2026-02-13
2025-09-30	$2,843	1,281	-85.7%	Shares	Defined	2025-11-10
2025-06-30	$9,818	8,927	-74.5%	Shares	Defined	2025-08-11
2025-03-31	$34,339	35,040	-16.7%	Shares	Defined	2025-05-12
2024-12-31	$65,656	42,088	+18.3%	Shares	Defined	2025-02-12
2024-09-30	$130,559	35,575	+224.5%	Shares	Defined	2024-11-12
2024-06-30	$36,284	10,962	-75.5%	Shares	Defined	2024-08-12
2024-03-31	$190,400	44,695	-87.5%	Shares	Defined	2024-05-10
2022-12-31	$479,099	357,537	+14.5%	Shares	Defined	2023-02-09
2022-09-30	$615,246	312,308	-0.0%	Shares	Defined	2022-11-10
2022-06-30	$743,538	312,411	+34.0%	Shares	Defined	2022-08-10
2022-03-31	$941,841	233,129	+7171.6%	Shares	Defined	2022-05-12
2021-12-31	$35,169	3,206	—	Shares	Defined	2022-02-10
No filing history on record for this holder in this stock.